Table 1 The clinical information and sample size for TCGA KIRC dataset.

From: Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data

Characteristics

LIVING (N = 605)

DECEASED (N = 340)

Total (N = 945)

FDR

Cancer type

 

Kidney clear cell renal carcinoma

605 (64.02%)

340 (35.98%)

945 (100.00%)

 

Age

 

Mean ± SD

58.74 ± 11.72

64.53 ± 11.82

60.82 ± 12.08

 

Median [min, max]

59.00 [26.00, 86.00]

64.00 [32.00, 90.00]

61.00 [26.00, 90.00]

 

Gender

0.36

Female

203 (21.48%)

125 (13.23%)

328 (34.71%)

 

Male

402 (42.54%)

215 (22.75%)

617 (65.29%)

 

Stage

9.20E-44

Stage I

369 (39.17%)

87 (9.24%)

456 (48.41%)

 

Stage II

72 (7.64%)

25 (2.65%)

97 (10.30%)

 

Stage III

133 (14.12%)

98 (10.40%)

231 (24.52%)

 

Stage IV

30 (3.18%)

128 (13.59%)

158 (16.77%)

 
Back to article page